Skip to main content
Top
Published in: BMC Cancer 1/2016

Open Access 01-12-2016 | Erratum

Erratum to: Involvement of DNMT 3B promotes epithelial-mesenchymal transition and gene expression profile of invasive head and neck squamous cell carcinomas cell lines

Authors: Li-Hsuen Chen, Wen-Lin Hsu, Yen-Ju Tseng, Dai-Wei Liu, Ching-Feng Weng

Published in: BMC Cancer | Issue 1/2016

Login to get access

Excerpt

After publication of the original article [1], the authors noticed an error within Figs. 3 and 5: Figures 3a and 5a were inadvertently missed. The full versions of Figs. 3 and 5 have been updated in the original article and can be found below. We would like to apologise for the error and for any inconvenience this may have caused.
Literature
Metadata
Title
Erratum to: Involvement of DNMT 3B promotes epithelial-mesenchymal transition and gene expression profile of invasive head and neck squamous cell carcinomas cell lines
Authors
Li-Hsuen Chen
Wen-Lin Hsu
Yen-Ju Tseng
Dai-Wei Liu
Ching-Feng Weng
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2016
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-016-2560-2

Other articles of this Issue 1/2016

BMC Cancer 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine